medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2022, Number 3

<< Back Next >>

Rev Med UAS 2022; 12 (3)

COVID-19: Review of the scientific evidence about clinical manifestations, diagnosis, treatment and prevention

Martínez-Salazar M, Juárez-González K, Castillo-Pérez JJ, Vázquez-Vega S

Language: Spanish
References: 48
Page: 238-256
PDF size: 793.35 Kb.


ABSTRACT

Never before in the history of science has so much information been generated in real time on a health phenomenon as with COVID- 19. The way of evaluating, approaching, diagnosing, treating, preventing and detecting the sequelae of this disease, from its appearance until the publication of this work, has been changing. Health professionals have faced one of the greatest challenges in their work, especially in countries such as ours, where health systems show so many problems. The following review was elaborated from the consultation of different bibliographic databases: Pubmed, Medline, Scopus, Lilacs, Science direct, Scielo, Ovid and official pages of PAHO (Pan American Health Organization) and WHO (World Health Organization) to contribute with scientific evidence on the clinical manifestations, diagnosis and prevention of COVID-19, and to contribute to clinical practice.


REFERENCES

  1. Wu F, Zhao S, Yu B, Chen Y-M, Wang W,Song Z-G, et al. A new coronavirus associatedwith human respiratory disease inChina. Nature [Internet]. 2020Mar;579(7798):265–9. Available from:http://dx.doi.org/10.1038/s41586-020-2008-3

  2. Zhou P, Yang X-L, Wang X-G, Hu B, ZhangL, Zhang W, et al. A pneumonia outbreak associatedwith a new coronavirus of probablebat origin. Nature [Internet]. 2020Mar;579(7798):270–3. Available from:http://dx.doi.org/10.1038/s41586-020-2012-7

  3. Zhu N, Zhang D, Wang W, Li X, Yang B,Song J, et al. A Novel Coronavirus from Patientswith Pneumonia in China, 2019. NEngl J Med [Internet]. 2020 Feb20;382(8):727–33. Available from:http://dx.doi.org/10.1056/NEJMoa2001017

  4. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, etal. Genomic characterisation and epidemiologyof 2019 novel coronavirus: implicationsfor virus origins and receptor binding.Lancet [Internet]. 2020 Feb22;395(10224):565–74. Available from:https://linkinghub.elsevier.com/retrieve/pii/S0140673620302518

  5. ¿Cuál es la diferencia entre brote, epidemiay pandemia? [Internet]. 2020 [cited 2021Sep 6]. Available from: https://gacetamedica.com/investigacion/cual-es-la-diferencia-entre-brote-epidemia-y-pandemia/

  6. Gorbalenya AE, Enjuanes L, Ziebuhr J, SnijderEJ. Nidovirales: evolving the largestRNA virus genome. Virus Res [Internet].2006 Apr;117(1):17–37. Available from:https://linkinghub.elsevier.com/retrieve/pii/S0168170206000360

  7. Korber B, Fischer WM, Gnanakaran S, YoonH, Theiler J, Abfalterer W, et al. TrackingChanges in SARS-CoV-2 Spike: Evidencethat D614G Increases Infectivity of the COVID-19 Virus. Cell [Internet]. 2020 Aug20;182(4):812–27.e19. Available from:http://dx.doi.org/10.1016/j.cell.2020.06.043

  8. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z,Oyewunmi OD, Camargo C, Nikpour B, et al.Tools and Techniques for Severe AcuteRespiratory Syndrome Coronavirus 2(SARS-CoV-2)/COVID-19 Detection. ClinMicrobiol Rev [Internet]. 2021 Jun 16;34(3).Available from:http://dx.doi.org/10.1128/CMR.00228-20

  9. Pohl MO, Busnadiego I, Kufner V, Glas I, KarakusU, Schmutz S, et al. SARS-CoV-2 variantsreveal features critical for replication inprimary human cells. PLoS Biol [Internet].2021 Mar;19(3):e3001006. Available from:http://dx.doi.org/10.1371/journal.pbio.3001006

  10. Seguimiento de las variantes del SARSCoV-2 [Internet]. [cited 2021 Sep 7]. Availablefrom: https://www.who.int/es/activities/tracking-SARS-CoV-2-variants

  11. [No title] [Internet]. [cited 2021 Sep 7]. Availablefrom: https://reliefweb.int/sites/reliefweb.int/files/resources/download_26.pdf

  12. Schön MP, Berking C, Biedermann T, BuhlT, Erpenbeck L, Eyerich K, et al. COVID-19and immunological regulations - from basicand translational aspects to clinical implications.J Dtsch Dermatol Ges [Internet]. 2020Aug;18(8):795–807. Available from:http://dx.doi.org/10.1111/ddg.14169

  13. Sun P, Lu X, Xu C, Sun W, Pan B. Understandingof COVID-19 based on currentevidence. J Med Virol [Internet]. 2020Jun;92(6):548–51. Available from:http://dx.doi.org/10.1002/jmv.25722

  14. Moore JB, June CH. Cytokine release syndromein severe COVID-19. Science [Internet].2020 May 1;368(6490):473–4. Availablefrom:http://dx.doi.org/10.1126/science.abb8925

  15. Hannan MA, Rahman MA, Rahman MS,Sohag AAM, Dash R, Hossain KS, et al. Intermittentfasting, a possible priming tool forhost defense against SARS-CoV-2 infection:Crosstalk among calorie restriction, autophagyand immune response. Immunol Lett[Internet]. 2020 Oct;226:38–45. Availablefrom: http://dx.doi.org/10.1016/j.imlet.2020.07.001

  16. Oliveira DS, Medeiros NI, Gomes JAS. Immuneresponse in COVID-19: What do wecurrently know? Microb Pathog [Internet].2020 Nov;148:104484. Available from:http://dx.doi.org/10.1016/j.micpath.2020.104484

  17. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y,Davenport C, Leeflang MM, et al. Signs andsymptoms to determine if a patient presentingin primary care or hospital outpatientsettings has COVID-19. Cochrane DatabaseSyst Rev [Internet]. 2021 Feb23;2:CD013665. Available from:http://dx.doi.org/10.1002/14651858.CD013665.pub2

  18. Current diagnostic approaches to detect twoimportant betacoronaviruses: Middle Eastrespiratory syndrome coronavirus (MERSCoV)and severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2). Pathology- Research and Practice [Internet]. 2021Sep 1 [cited 2021 Sep 7];225:153565. Availablefrom:http://dx.doi.org/10.1016/j.prp.2021.153565

  19. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G,et al. Detection of SARS-CoV-2 in DifferentTypes of Clinical Specimens. JAMA [Internet].

  20. 2020 May 12;323(18):1843–4. Availablefrom:http://dx.doi.org/10.1001/jama.2020.378620. Hemida MG. The next􀇦generation coronavirusdiagnostic techniques with particularemphasis on the SARS􀇦CoV􀇦2 [Internet].Vol. 93, Journal of Medical Virology. 2021. p.4219–41. Available from:http://dx.doi.org/10.1002/jmv.26926

  21. Langa LS, Sallent LV, Díez SR. 167-17310.1016/j.Fmc.2021.01.005 Langa LauraSoldevila LS programa de Salud internacional(PROSICS) metropolitana Norte, serviciode enfermedades infecciosas, hospital UniversitariGermans Trias i Pujol. Sallent lluísValerio LV programa de Salud internacional(PROSICS) metropolitana Norte, servicio deatención primaria, Badalona, Barcelona, España.Díez sílvia Roure SR programa de Saludinternacional (PROSICS) metropolitanaNorte, servicio de enfermedades infecciosas,hospital Universitari Germans Trias iPujol. Spa journal article interpretación delas pruebas diagnósticas de la COVID-19.2021 03 23. FMC - Form Médica Contin AtenPrimaria [Internet]. 2021 Mar;28(3):167–73.Available from: https://linkinghub.elsevier.com/retrieve/pii/S1134207221000220

  22. Preparedness E. Diagnostic testing forSARS-CoV-2 [Internet]. World Health Organization;2020 [cited 2021 Sep 14]. Availablefrom: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2

  23. Brümmer LE, Katzenschlager S, GaeddertM, Erdmann C, Schmitz S, Bota M, et al. Accuracyof novel antigen rapid diagnostics forSARS-CoV-2: A living systematic review andmeta-analysis. PLoS Med [Internet]. 2021Aug 12 [cited 2021 Sep 7];18(8):e1003735.Available from: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003735&type=printable

  24. La Marca A, Capuzzo M, Paglia T, Roli L,Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinicalguide to molecular and serological in-vitrodiagnostic assays. Reprod Biomed Online[Internet]. 2020 Sep;41(3):483–99. Availablefrom:http://dx.doi.org/10.1016/j.rbmo.2020.06.001

  25. [No title] [Internet]. [cited 2021 Sep 7]. Availablefrom:https://apps.who.int/iris/bitstream/handle/10665/338330/WHO-2019-nCoV-Surveillance_Case_Definition-2020.2-spa.pdf?sequence=1&isAllowed=y

  26. Machhi J, Herskovitz J, Senan AM, Dutta D,Nath B, Oleynikov MD, et al. The NaturalHistory, Pathobiology, and Clinical Manifestationsof SARS-CoV-2 Infections. J NeuroimmunePharmacol [Internet]. 2020Sep;15(3):359–86. Available from:http://dx.doi.org/10.1007/s11481-020-09944-5

  27. Izcovich A, Ragusa M, Tortosa F, LavenaMarzio MA, Agnoletti C, Bengolea A, et al.Prognostic Factors for Severity and Mortalityin Patients Infected with COVID-19: A SystematicReview. 2020 Jun 11 [cited 2021 Sep7]; Available from: https://papers.ssrn.com/abstract=3627285

  28. Sisay T, Tolessa T. COVID-19 Pandemic: ACompressive Review on Gender, Herd Immunity,and Physiological Mechanisms. RiskManag Healthc Policy [Internet]. 2020 Dec14;13:2963–74. Available from:http://dx.doi.org/10.2147/RMHP.S276342

  29. Las infecciones fúngicas en la pandemia deCOVID-19, el caso de la mucormicosis. RevistaArgentina de Microbiología [Internet].2021 Jul 1 [cited 2021 Oct 4];53(3):181–2.Available from:http://dx.doi.org/10.1016/j.ram.2021.09.001

  30. Mahalaxmi I, Jayaramayya K, VenkatesanD, Subramaniam MD, Renu K, VijayakumarP, et al. Mucormycosis: An opportunisticpathogen during COVID-19. Environ Res [Internet].2021 Oct;201:111643. Availablefrom: http://dx.doi.org/10.1016/j.envres.2021.111643

  31. Sen M, Honavar SG, Bansal R, Sengupta S,Rao R, Kim U, et al. Epidemiology, clinicalprofile, management, and outcome of COVID-19-associated rhino-orbital-cerebralmucormycosis in 2826 patients in India - CollaborativeOPAI-IJO Study on Mucormycosisin COVID-19 (COSMIC), Report 1. IndianJ Ophthalmol [Internet]. 2021Jul;69(7):1670–92. Available from:http://dx.doi.org/10.4103/ijo.IJO_1565_21

  32. Rodriguez-Morales AJ, Mamani-García CS,Nuñez-Lupaca JN, León-Figueroa DA,Olarte-Durand M, Yrene-Cubas RA, et al.COVID-19 and mucormycosis in Latin America- An emerging concern. Travel Med InfectDis [Internet]. 2021 Aug 25;44:102156.Available from:http://dx.doi.org/10.1016/j.tmaid.2021.102156

  33. Wali AA, Abd-El-Fatah SM. Prognosis andOutcomes of COVID-19 infection DuringPregnancy. In: Covid-19 Infections andPregnancy [Internet]. Elsevier; 2021. p. 145–65. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323905954000030

  34. Wastnedge EAN, Reynolds RM, vanBoeckel SR, Stock SJ, Denison FC, MaybinJA, et al. Pregnancy and COVID-19. PhysiolRev [Internet]. 2021 Jan 1;101(1):303–18.Available from:http://dx.doi.org/10.1152/physrev.00024.2020

  35. Mirbeyk M, Saghazadeh A, Rezaei N. A systematicreview of pregnant women with COVID-19 and their neonates. Arch GynecolObstet [Internet]. 2021 Jul;304(1):5–38.Available from:http://dx.doi.org/10.1007/s00404-021-06049-z

  36. Di Mascio D, Buca D, Berghella V, Khalil A,Rizzo G, Odibo A, et al. Counseling in maternal-fetal medicine: SARS-CoV-2 infectionin pregnancy. Ultrasound Obstet Gynecol[Internet]. 2021 May;57(5):687–97. Availablefrom:http://dx.doi.org/10.1002/uog.23628

  37. Novoa RH, Quintana W, Llancarí P, Urbina-Quispe K, Guevara-Ríos E, Ventura W. Maternalclinical characteristics and perinataloutcomes among pregnant women with coronavirusdisease 2019. A systematic review.Travel Med Infect Dis [Internet]. 2021Jan;39:101919. Available from:http://dx.doi.org/10.1016/j.tmaid.2020.101919

  38. Siebach MK, Piedimonte G, Ley SH. COVID-19 in childhood: Transmission, clinical presentation,complications and risk factors. PediatrPulmonol [Internet]. 2021Jun;56(6):1342–56. Available from:http://dx.doi.org/10.1002/ppul.25344

  39. Perikleous E, Tsalkidis A, Bush A, ParaskakisE. Coronavirus global pandemic: Anoverview of current findings among pediatricpatients. Pediatr Pulmonol [Internet]. 2020Dec;55(12):3252–67. Available from:http://dx.doi.org/10.1002/ppul.25087

  40. Oliva Marin JE. COVID-19 en niñez y adolescencia.Alerta [Internet]. 2021 Jan14;4(1):48–60. Available from:https://www.lamjol.info/index.php/alerta/article/view/9780

  41. Lopez-Leon S, Wegman-Ostrosky T, PerelmanC, Sepulveda R, Rebolledo PA, CuapioA, et al. More than 50 Long-term effects ofCOVID-19: a systematic review and metaanalysis.medRxiv [Internet]. 2021 Jan 30;Available from:http://dx.doi.org/10.1101/2021.01.27.21250617

  42. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus DiseaseEvolution, Transmission, Detection,Control and Prevention. Viruses [Internet].2021 Jan 29;13(2). Available from:http://dx.doi.org/10.3390/v13020202

  43. Yong SJ. Long COVID or post-COVID-19syndrome: putative pathophysiology, riskfactors, and treatments. Infect Dis [Internet].2021 Oct;53(10):737–54. Available from:http://dx.doi.org/10.1080/23744235.2021.1924397

  44. COVID-19 therapy: What weapons do webring into battle? Bioorg Med Chem [Internet].2020 Dec 1 [cited 2021 Sep8];28(23):115757. Available from:http://dx.doi.org/10.1016/j.bmc.2020.115757

  45. Website [Internet]. Available from: https://coronavirus.gob.mx/wp-content/uploads/2021/08/GuiaTx_COVID19_ConsensoInterinstitucional_2021.08.03

  46. Pormohammad A, Zarei M, Ghorbani S,Mohammadi M, Razizadeh MH, Turner DL,et al. Efficacy and Safety of COVID-19 Vaccines:A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Vaccines(Basel) [Internet]. 2021 May 6;9(5).Available from:http://dx.doi.org/10.3390/vaccines9050467

  47. Website [Internet]. Available from: https://coronavirus.gob.mx/wp-content/uploads/2021/03/GTApp_Cansino_16Mar2021.pdf

  48. Creech CB, Walker SC, Samuels RJ. SARSCoV-2 Vaccines. JAMA [Internet]. 2021 Apr6;325(13):1318–20. Available from:http://dx.doi.org/10.1001/jama.2021.3199




2020     |     www.medigraphic.com